Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Cytopenias and Failure to Use Innovative Therapy Are Main Drivers of Worse Outcome after Discontinuation of Ruxolitinib in Myelofibrosis

Blood (2024) 144 (Supplement 1): 6664.

https://doi.org/10.1182/blood-2024-199961

Published: 2024

Journal Articles

ROP-ET: A Prospective Phase III Trial Investigating the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythemia Patients with Limited Treatment Options

Blood (2024) 144 (Supplement 1): 6635.

https://doi.org/10.1182/blood-2024-199028

Published: 2024

Journal Articles

The Association of Anemia and Patient Reported Outcomes in the New Era of PNH Treatment

Blood (2024) 144 (Supplement 1): 2321.

https://doi.org/10.1182/blood-2024-204693

Published: 2024

Journal Articles

Reaction - Real Life Use of Ravulizumab in Italian Patients with Paroxysmal Nocturnal Hemoglobinuria a Multicenter Observational Retrospective and Prospective Cohort Study, Final Results

Blood (2024) 144 (Supplement 1): 2464.

https://doi.org/10.1182/blood-2024-204659

Published: 2024

Journal Articles

Factor B Inhibition with Oral Iptacopan Monotherapy Demonstrates Sustained Long-Term Efficacy and Safety in Anti-C5-Treated Patients (pts) with Paroxysmal Nocturnal Hemoglobinuria (PNH) and Persistent Anemia: Final 48-Week Results from the Multicenter, Phase III APPLY-PNH Trial

Blood (2023) 142 (Supplement 1): 571.

https://doi.org/10.1182/blood-2023-180780

Published: 2023

Journal Articles

Health-Related Quality of Life and Symptom Burden Profile of Patients with Pre-Fibrotic and Overt Myelofibrosis: A Preliminary Report from the Gimema-Prophecy Observational Study

Blood (2023) 142 (Supplement 1): 2441.

https://doi.org/10.1182/blood-2023-186429

Published: 2023

Journal Articles

Peripheral Blasts Are Associated with Response to Ruxolitinib and Outcome in Patients with Chronic-Phase Myelofibrosis

Blood (2021) 138 (Supplement 1): 3624.

https://doi.org/10.1182/blood-2021-152420

Published: 2021

Journal Articles

Sars-Cov-2 Vaccination in Patients with Paroxysmal Nocturnal Hemoglobinuria: An Italian Multicenter Survey

Juri Alessandro Giannotta, Bruno Fattizzo, Corrado Girmenia, Claudia Ielo, Elisabetta Metafuni, Adele Visentin, Paola Bianchi, Vincenzo Apolito, Eloise Beggiato, Eros Di Bona, Simona Sica, Anna Paola Iori, Wilma Barcellini

Blood (2021) 138 (Supplement 1): 2180.

https://doi.org/10.1182/blood-2021-150328

Published: 2021

Journal Articles

COVID-19 Infection in Patients with Paroxysmal Nocturnal Hemoglobinuria in Italy

Wilma Barcellini, Bruno Fattizzo, MD, Luisa Quattrocchi, Juri Alessandro Giannotta, MD, Semra Aydin, MD PhD, Federica Barone, MD, Cecilia Carbone, MD, Eloise Beggiato, Paola Bianchi, BSc, PhD, Eros Di Bona, MD, Rosario Notaro, MD, Anna Paola Iori

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-138721

Published: 2020

Journal Articles

A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia

Blood (2020) 136 (2): 171–182.

https://doi.org/10.1182/blood.2019004596

Published: 2020

Includes: Supplemental data

Journal Articles

Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study

Blood (2020) 135 (5): 381–386.

https://doi.org/10.1182/blood.2019002614

Published: 2020

Includes: Supplemental data

Journal Articles

Impact of Comorbidities and Body Mass Index in Patients with Polycythemia Vera: A PV-NET Real World Study

Blood (2019) 134 (Supplement_1): 4184.

https://doi.org/10.1182/blood-2019-125387

Published: 2019

Journal Articles

Frequency of Thrombosis Is Higher in MPN Patients Who Develop Second Cancer Than in Controls

Valerio De Stefano, MD, Arianna Ghirardi, PhD, Arianna Masciulli, PhD, Alessandra Carobbio, BSc, Francesca Palandri, PhD MD, Nicola Vianelli, MD, Elena Rossi, MD PhD, Silvia Betti, MD PhD, Ambra Di Veroli, MD, Alessandra Iurlo, MD PhD, Daniele Cattaneo, MD, Guido Finazzi, MD, Massimiliano Bonifacio, MD, Luigi Scaffidi, MD, Andrea Patriarca, MD, Elisa Rumi, MD, Ilaria Carola Casetti, MD, Clemency Stephenson, MD, Paola Guglielmelli, MD PhD, Elena Maria Elli, MD, Miroslava Palova, MD, Davide Rapezzi, MD, Daniel Erez, MD, Montse Gomez, MD, Kai Wille, MD, Manuel Pérez-Encinas, MD, Francesca Lunghi, MD, Anna Angona, MD PhD, Maria Laura Fox, MD, Eloise Beggiato, MD, Giulia Benevolo, MD, Giuseppe Carli, MD, Rossella Rosaria Cacciola, MD, Mary Frances McMullin, MD FRCPath, FRCP, Alessia Tieghi, MD, Valle Recasens, MD, Monia Marchetti, MD, Martin Griesshammer, MD, Alberto Alvarez-Larrán, MD PhD, Alessandro M. Vannucchi, MD, Alessandro Rambaldi, MD PhD, Tiziano Barbui, MD

Blood (2019) 134 (Supplement_1): 4170.

https://doi.org/10.1182/blood-2019-127982

Published: 2019

Journal Articles

Risk Factors for Secondary Cancer in a Case-Control Study on 1,259 Patients with Myeloproliferative Neoplasms

Tiziano Barbui, MD, Arianna Ghirardi, PhD, Arianna Masciulli, PhD, Alessandra Carobbio, MSc, Francesca Palandri, PhD MD, Nicola Vianelli, MD, Valerio De Stefano, MD, Silvia Betti, MD, Ambra Di Veroli, MD, Alessandra Iurlo, Daniele Cattaneo, MD, Federica Delaini, MSc, Massimiliano Bonifacio, MD, Luigi Scaffidi, MD, Andrea Patriarca, MD, Elisa Rumi, MD, Clemency Stephenson, MD, Paola Guglielmelli, MD PhD, Elena Maria Elli, MD, Palova Miroslava, MD, Laura Bertolotti, MSc, Daniel Erez, MD, Montse Gomez, MD, Kai Wille, MD, Manuel Pérez-Encinas, MD, Francesca Lunghi, Anna Angola Figueras, MD, Maria Laura Fox, MD, Eloise Beggiato, MD, Giulia Benevolo, MD, Giuseppe Carli, MD, Rossella Rosari Cacciola, Mary Frances McMullin, MD, Alessia Tieghi, MD, Valle Recanses Flores, MD, Monia Marchetti, Martin Griesshammer, MD PhD, Alberto Alvarez-Larran, MD, Alessandro M. Vannucchi, MD, Guido Finazzi, MD

Blood (2018) 132 (Supplement 1): 4279.

https://doi.org/10.1182/blood-2018-99-112387

Published: 2018

Journal Articles

Short and Long-Term Risk of Major Cardiovascular Events after Ischemic Stroke or Transient Ischemic Attack in Myeloproliferative Neoplasms

Tiziano Barbui, MD, Valerio De Stefano, MD, Alessandra Carobbio, MSc, Vincenzo Di Lazzaro, MD, Paola Guglielmelli, MD PhD, Giuseppe Gaetano Loscocco, MD, Alessandra Iurlo, MD PhD, Daniele Cattaneo, MD, Agostino Cortelezzi, Prof, Silvia Betti, MD, Elena Rossi, MD, Maria Chiara Finazzi, MD, Guido Finazzi, MD, Bruno Censori, MD, Mario Cazzola, MD, Elisa Rumi, MD, Marta Bellini, MD, Francisco Cervantes, MD, Eduardo Arellano-Rodrigo, MD, Elena Elli, MD, Maria Luigia Randi, MD, Irene Bertozzi, MD, Martin Griesshammer, MD, Parvis Sadjadian, MD, Francesca Palandri, PhD MD, Nicola Vianelli, Massimiliano Bonifacio, MD, Luigi Scaffidi, Juan Carlos Hernandez-Boluda, MD, Montse Gomez, MD, Emma Cacciola, MD, Rossella Rosari Cacciola, MD, Palova Miroslava, MD, Giuseppe Carli, MD, Eloise Beggiato, MD, Martin H Ellis, MD, Caterina Musolino, MD, Gianluca Gaidano, MD PhD, Davide Rapezzi, MD, Alessia Tieghi, MD, Francesca Lunghi, MD, Alessandro M. Vannucchi

Blood (2017) 130 (Supplement 1): 202.

https://doi.org/10.1182/blood.V130.Suppl_1.202.202

Published: 2017

Journal Articles

Patients with Unexplained Thrombosis Require a Prompt Investigation to Search a Chronic Myeloproliferative Neoplasm (MPN), Even If Platelet Count Is <600x10 9 /L. Analysis on 129 Patients from Registro Italiano Trombocitemie (RIT)

Giulia Benevolo, MD, Alessandra Iurlo, MD PhD, Gabriele Gugliotta, PhD, Alessia Tieghi, MD, Gianluca Gaidano, MD PhD, Giuseppe Tagariello, MD, Bruno Martino, MD, Mauro Di Ianni, MD, Potito Rosario Scalzulli, MD, Vincenzo Martinelli, MD, Umberto Santoro, MD, Eloise Beggiato, MD, Maria Luigia Randi, MD, Giorgina Specchia, Francesco Passamonti, Alessandro M. Vannucchi, MD, Umberto Vitolo, Luigi Gugliotta, MD

Blood (2015) 126 (23): 5181.

https://doi.org/10.1182/blood.V126.23.5181.5181

Published: 2015

Journal Articles

Impact of Age, Therapy and Molecular Profile in Myelofibrosis Patients. Analysis on 123 Patients from a Single Italian Haematological Center

Giulia Benevolo, MD, Eloise Beggiato, MD, Ludovica Riera, BSc, PhD, Andrea Evangelista, Anna Campana, Barbara Nicolino, MD, Maura Nicolosi, MD, Lucia Biale, MD, Dario Ferrero, MD, Umberto Vitolo

Blood (2015) 126 (23): 5188.

https://doi.org/10.1182/blood.V126.23.5188.5188

Published: 2015

Journal Articles

Immunogenetic Characterization of Primary Immune Thrombocytopenia (ITP) in Adults: Results of the Unit Study

Francesco Zaja, Elena Boggio, Davide Rossi, MD PhD, Casimiro L. Gigliotti, Eleonora Toffoletti, Giuseppe Cappellano, Orilieri Elisabetta, Simona Puglisi, Monia Lunghi, Nicola Vianelli, MD, Silvia Cantoni, Alessia Tieghi, Eloise Beggiato, Gianluca Gaidano, Miriam Isola, Renato Fanin, Umberto Dianzani

Blood (2014) 124 (21): 1461.

https://doi.org/10.1182/blood.V124.21.1461.1461

Published: 2014

Journal Articles

Prognostic Value of JAK2V617F, Calr and MPL Mutational Status on Outcome and Thrombotic Risk in a Retrospective Cohort of 138 Patients with Essential Thrombocythemia

Giulia Benevolo, MD, Ludovica Riera, PhD, Barbara Nicolino, MD, Andrea Evangelista, Eloise Beggiato, MD, Chiara Aguzzi, MD, Maura Nicolosi, MD, Chiara Frairia, MD, Umberto Vitolo, MD

Blood (2014) 124 (21): 5553.

https://doi.org/10.1182/blood.V124.21.5553.5553

Published: 2014

Journal Articles

Retrospective Analysis Of 204 Patients With Polycythemia VERA: The International Working Group For Myeloproliferative Neoplasm Research and Treatment (IWG-MRT) Prognostic Score Is A Good Predictor Of Survival and Prognosis

Giulia Benevolo, MD, Elena Crisà, MD, Barbara Nicolino, MD, Patrizia Pregno, MD, Eloise Beggiato, MD, Andrea Evangelista, Dario Ferrero, MD, Laura Godio, Mario Boccadoro, MD, Umberto Vitolo, MD

Blood (2013) 122 (21): 4072.

https://doi.org/10.1182/blood.V122.21.4072.4072

Published: 2013

NARROW

Cytopenias and Failure to Use Innovative Therapy Are Main Drivers of Worse Outcome after Discontinuation of Ruxolitinib in Myelofibrosis

ROP-ET: A Prospective Phase III Trial Investigating the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythemia Patients with Limited Treatment Options

The Association of Anemia and Patient Reported Outcomes in the New Era of PNH Treatment

Reaction - Real Life Use of Ravulizumab in Italian Patients with Paroxysmal Nocturnal Hemoglobinuria a Multicenter Observational Retrospective and Prospective Cohort Study, Final Results

Factor B Inhibition with Oral Iptacopan Monotherapy Demonstrates Sustained Long-Term Efficacy and Safety in Anti-C5-Treated Patients (pts) with Paroxysmal Nocturnal Hemoglobinuria (PNH) and Persistent Anemia: Final 48-Week Results from the Multicenter, Phase III APPLY-PNH Trial

Health-Related Quality of Life and Symptom Burden Profile of Patients with Pre-Fibrotic and Overt Myelofibrosis: A Preliminary Report from the Gimema-Prophecy Observational Study

Peripheral Blasts Are Associated with Response to Ruxolitinib and Outcome in Patients with Chronic-Phase Myelofibrosis

Sars-Cov-2 Vaccination in Patients with Paroxysmal Nocturnal Hemoglobinuria: An Italian Multicenter Survey

COVID-19 Infection in Patients with Paroxysmal Nocturnal Hemoglobinuria in Italy

A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia

Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study

Impact of Comorbidities and Body Mass Index in Patients with Polycythemia Vera: A PV-NET Real World Study

Frequency of Thrombosis Is Higher in MPN Patients Who Develop Second Cancer Than in Controls

Risk Factors for Secondary Cancer in a Case-Control Study on 1,259 Patients with Myeloproliferative Neoplasms

Short and Long-Term Risk of Major Cardiovascular Events after Ischemic Stroke or Transient Ischemic Attack in Myeloproliferative Neoplasms

Patients with Unexplained Thrombosis Require a Prompt Investigation to Search a Chronic Myeloproliferative Neoplasm (MPN), Even If Platelet Count Is <600x10 9 /L. Analysis on 129 Patients from Registro Italiano Trombocitemie (RIT)

Impact of Age, Therapy and Molecular Profile in Myelofibrosis Patients. Analysis on 123 Patients from a Single Italian Haematological Center

Immunogenetic Characterization of Primary Immune Thrombocytopenia (ITP) in Adults: Results of the Unit Study

Prognostic Value of JAK2V617F, Calr and MPL Mutational Status on Outcome and Thrombotic Risk in a Retrospective Cohort of 138 Patients with Essential Thrombocythemia

Retrospective Analysis Of 204 Patients With Polycythemia VERA: The International Working Group For Myeloproliferative Neoplasm Research and Treatment (IWG-MRT) Prognostic Score Is A Good Predictor Of Survival and Prognosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only